Persistent Asset Partners »

Crispr Therapeutics Ag call shares owned by Persistent Asset Partners

Quarter-by-quarter ownership of Crispr Therapeutics Ag call shares owned by Persistent Asset Partners from 13F filings

Historical chart of Persistent Asset Partners investment in Crispr Therapeutics Ag call

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics Ag call held by Persistent Asset Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics Ag call by Persistent Asset Partners

Quarter filed Position value Share count Share price at filing
2025-09-30 $282k 258 1094.43

More positions owned by Persistent Asset Partners

Centene Corporation (CNC)
Ishares Tr 7-10 Yr Trsy Bd (IEF)
UnitedHealth (UNH)
Regeneron Pharmaceuticals (REGN)
CVS Caremark Corporation (CVS)
Nebius Group Shs Class A (NBIS)
Pdd Holdings Sponsored Ads (PDD)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Soleno Therapeutics (SLNO)
BioMarin Pharmaceutical (BMRN)
Labcorp Holdings Com Shs (LH)
Anthem (ELV)
Healthcare Services (HCSG)
Quest Diagnostics Incorporated (DGX)
Brightspring Health Svcs (BTSG)

View all positions for Persistent Asset Partners

Top funds holding Crispr Therapeutics Ag call

IMC-Chicago
Group One Trading
Simplex Trading
Maven Securities
National Bank Of Canada /fi/
Persistent Asset Partners
Hurley Capital
Advisor Group Holdings

View all funds holding Crispr Therapeutics Ag call